In March 2025, the company announced new programs for your direct-to-client offering of its Wegovy weight loss drug. The company founded a fresh pharmacy, identified as NovoCare, which would charge buyers $499 every month for access to the drug, under fifty percent the price of the drug by means of other pharmaceutical distribution networks.[fifty